AbCellera Biologics (ABCL) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to $223.4 million.
- AbCellera Biologics' Other Gross PP&E Adjustments rose 7.05% to $223.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $867.0 million, marking a year-over-year increase of 4.73%. This contributed to the annual value of $210.3 million for FY2024, which is 36.41% up from last year.
- According to the latest figures from Q3 2025, AbCellera Biologics' Other Gross PP&E Adjustments is $223.4 million, which was up 1.72% from $219.6 million recorded in Q2 2025.
- In the past 5 years, AbCellera Biologics' Other Gross PP&E Adjustments ranged from a high of $233.8 million in Q2 2024 and a low of $31.0 million during Q1 2021.
- For the 3-year period, AbCellera Biologics' Other Gross PP&E Adjustments averaged around $213.3 million, with its median value being $216.9 million (2023).
- In the last 5 years, AbCellera Biologics' Other Gross PP&E Adjustments spiked by 332.35% in 2021 and then decreased by 7.57% in 2025.
- Over the past 5 years, AbCellera Biologics' Other Gross PP&E Adjustments (Quarterly) stood at $101.6 million in 2021, then spiked by 52.39% to $154.9 million in 2022, then fell by 0.47% to $154.2 million in 2023, then soared by 36.41% to $210.3 million in 2024, then rose by 7.05% to $223.4 million in 2025.
- Its Other Gross PP&E Adjustments was $223.4 million in Q3 2025, compared to $219.6 million in Q2 2025 and $213.7 million in Q1 2025.